---
id: 676
title: 'Kauffman report: Biomedical IPOs had the highest survival and lowest bankruptcy rates among all sectors'
date: 2012-05-25T16:57:39+00:00
author: kanteron
layout: post
guid: https://www.kanteron.com/blog/?p=676
permalink: /blog/2012/05/25/kauffman-report-biomedical-ipos-had-the-highest-survival-and-lowest-bankruptcy-rates-among-all-sectors/
categories:
  - Entrepreneurship
  - HealthCare
  - Kanteron
---
According to a <a title="https://www.kauffman.org/newsroom/slump-in-initial-public-offerings-bodes-poorly-for-us-employment-economic-growth.aspx" href="https://www.kauffman.org/newsroom/slump-in-initial-public-offerings-bodes-poorly-for-us-employment-economic-growth.aspx" target="_blank">Kauffman study</a>:

> Among Emerging Growth CompaniesÂ firms that made IPOs from 1996 through 2000, only 29 percent were still operating 10 years later. However, acquisition was a far more common outcome than was failure (55 percent vs. 16 percent). **Biomedical IPOs had the highest survival and lowest bankruptcy rates among all sectors**; the highest failure rates were in manufacturing and retail.